The use of LSD and ditran in the treatment of therapy resistant schizophrenics (symptom provocation approach).
D000328:Adult; D000704:Analysis of Variance; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004569:Electroencephalography; D006213:Hallucinogens / Q000627:therapeutic use*; D006801:Humans; D008238:Lysergic Acid Diethylamide / Q000627:therapeutic use*; D008875:Middle Aged; D010276:Parasympatholytics / Q000627:therapeutic use*; D010640:Phenothiazines / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy* / Q000503:physiopathology
D006213:Hallucinogens; D010276:Parasympatholytics; D010640:Phenothiazines; D008238:Lysergic Acid Diethylamide